Add to ORKGAlzheimer\u2019s disease is a dementia characterized by neuronal loss, athrophy, gliosis and clinically by progressive cognitive impairment. The apolipoprotein E type 4 allele is genetically associated with the common late onset familial and sporadic forms of Alzheimer's disease. Aim of this study was to evaluate and compare genotypic and allelic polymorphism of APO-E gene in a sample caucasoid AD patients with Mini Mental State Examination <24 and cognitively - normal control individuals
Alzheimer’s disease (AD) is a progressive neurodegenerative disease. Although it has been stud...
Apolipoprotein E (ApoE) is the major lipid-carrier protein in the brain, and several studies provide...
BACKGROUND:The risk of Alzheimer's disease (AD) appears to increase, and the age at onset to decreas...
The genetic basis for dementias is complex. A common polymorphism in the apolipoprotein E (APOE) gen...
Background: Alzheimers disease as a neurodegenerative disorder is the commonest type of dementia. A ...
We investigated the status of the apolipoprotein E allele in 538 participants in the incidence phase...
The Apolipoprotein E (APOE) epsilon 4 allele has been found to be strongly associated with Alzheimer...
We investigated the status of the apolipoprotein E allele in 538 participants in the incidence phase...
The ε4 allele of the apolipoprotein E (APOE) gene is a strong risk factor for developing late-onset ...
The accurate clinical diagnosis of Alzheimer’s disease can only be made with a high degree of certai...
Mild cognitive impairment (MCI) is the transition stage between the normal aging process and dement...
Specific Apolipoprotein E (ApoE) genotypes are thought to be associated with risk for Alzheimer's di...
Numerous studies have shown that the risk of Alzheimer's disease (AD) is associated with the dose of...
The role of the Apolipoprotein E (APOE) alleles in syndromes associated with focal cerebral atrophy ...
OBJECTIVE: There have been inconclusive results to date on the association between the Apolipoprote...
Alzheimer’s disease (AD) is a progressive neurodegenerative disease. Although it has been stud...
Apolipoprotein E (ApoE) is the major lipid-carrier protein in the brain, and several studies provide...
BACKGROUND:The risk of Alzheimer's disease (AD) appears to increase, and the age at onset to decreas...
The genetic basis for dementias is complex. A common polymorphism in the apolipoprotein E (APOE) gen...
Background: Alzheimers disease as a neurodegenerative disorder is the commonest type of dementia. A ...
We investigated the status of the apolipoprotein E allele in 538 participants in the incidence phase...
The Apolipoprotein E (APOE) epsilon 4 allele has been found to be strongly associated with Alzheimer...
We investigated the status of the apolipoprotein E allele in 538 participants in the incidence phase...
The ε4 allele of the apolipoprotein E (APOE) gene is a strong risk factor for developing late-onset ...
The accurate clinical diagnosis of Alzheimer’s disease can only be made with a high degree of certai...
Mild cognitive impairment (MCI) is the transition stage between the normal aging process and dement...
Specific Apolipoprotein E (ApoE) genotypes are thought to be associated with risk for Alzheimer's di...
Numerous studies have shown that the risk of Alzheimer's disease (AD) is associated with the dose of...
The role of the Apolipoprotein E (APOE) alleles in syndromes associated with focal cerebral atrophy ...
OBJECTIVE: There have been inconclusive results to date on the association between the Apolipoprote...
Alzheimer’s disease (AD) is a progressive neurodegenerative disease. Although it has been stud...
Apolipoprotein E (ApoE) is the major lipid-carrier protein in the brain, and several studies provide...
BACKGROUND:The risk of Alzheimer's disease (AD) appears to increase, and the age at onset to decreas...